| IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma JD Bard, P Gelebart, M Anand, Z Zak, SA Hegazy, HM Amin, R Lai The American journal of pathology 175 (2), 825-834, 2009 | 64 | 2009 |
| Genetic Screening for Synthetic Lethal Partners of Polynucleotide Kinase/Phosphatase: Potential for Targeting SHP-1–Depleted Cancers TR Mereniuk, RA Maranchuk, A Schindler, J Penner-Chea, GK Freschauf, ... Cancer research 72 (22), 5934-5944, 2012 | 55 | 2012 |
| Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma P Gelebart, SA Hegazy, P Wang, KM Bone, M Anand, D Sharon, M Hitt, ... Blood cancer journal 2 (8), e82-e82, 2012 | 44 | 2012 |
| Cysteine-rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis S Al Bashir, M Alshalalfa, SA Hegazy, M Dolph, B Donnelly, TA Bismar Journal of hematology & oncology 7, 1-11, 2014 | 38 | 2014 |
| Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients T Wang, H Abou-Ouf, SA Hegazy, M Alshalalfa, K Stoletov, J Lewis, ... Journal of Molecular Medicine 94, 1411-1422, 2016 | 32 | 2016 |
| High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer A Box, M Alshalalfa, SA Hegazy, B Donnelly, TA Bismar Tumor Biology 37, 12287-12299, 2016 | 31 | 2016 |
| Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification TA Bismar, S Hegazy, Z Feng, D Yu, B Donnelly, N Palanisamy, BJ Trock Journal of cancer research and clinical oncology 144, 2117-2125, 2018 | 28 | 2018 |
| Fusion tyrosine kinase NPM-ALK deregulates MSH2 and suppresses DNA mismatch repair function: novel insights into a potent oncoprotein LC Young, KM Bone, P Wang, F Wu, BA Adam, S Hegazy, P Gelebart, ... The American journal of pathology 179 (1), 411-421, 2011 | 22 | 2011 |
| microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients A Bakkar, M Alshalalfa, LF Petersen, H Abou-Ouf, A Al-Mami, SA Hegazy, ... Molecular biology reports 43, 229-240, 2016 | 21 | 2016 |
| ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients A Almami, SA Hegazy, A Nabbi, M Alshalalfa, A Salman, H Abou-Ouf, ... Tumor Biology 37, 9731-9738, 2016 | 19 | 2016 |
| The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor … SA Hegazy, P Wang, M Anand, RJ Ingham, P Gelebart, R Lai Journal of Biological Chemistry 285 (26), 19813-19820, 2010 | 19 | 2010 |
| The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma P Wang, JD Zhang, F Wu, X Ye, D Sharon, M Hitt, TP McMullen, ... Cellular signalling 24 (10), 1955-1963, 2012 | 18 | 2012 |
| The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy KC Huang, M Alshalalfa, SA Hegazy, M Dolph, B Donnelly, TA Bismar Cancer Biology & Therapy 15 (9), 1120-1128, 2014 | 17 | 2014 |
| Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma SA Hegazy, A Alshareef, P Gelebart, M Anand, H Armanious, RJ Ingham, ... Cellular signalling 25 (1), 295-307, 2013 | 16 | 2013 |
| Fostering Competencies: A Scoping Review of Escape Rooms in Medical Education GL Park, SA Hegazy, J Sepe, J Swigart, M Burnette, J Beltran, ... Medical Science Educator, 1-11, 2025 | 1 | 2025 |
| Validation of gene expression signatures for genomic identification of neuroendocrine prostate cancer S Hegazy, AW Wyatt, J Lehrer, H Abou Ouf, M Alshalalfa, EA Gibb, ... LABORATORY INVESTIGATION 97, 230A-230A, 2017 | | 2017 |
| Does ERG protein expression predict for relapse after a prostate brachytherapy implant? N Usmani, K Alkaabi, S Ghosh, J Hill, C Hackett, H Moore, A Box, ... Cureus Journal of Medical Science, 2015 | | 2015 |
| Cysteine-Rich Secretory Protein 3 (CRISP3), ERG and PTEN Define a Molecular Subtype of Prostate Cancer with Poorest Clinical Patient's Outcome S Al-Bashir, M Alshalalfa, S Hegazy, M Dolph, B Donnelly, T Bismar LABORATORY INVESTIGATION 94, 213A-213A, 2014 | | 2014 |
| Corrigendum to “Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma”[Cell. Signal. 2013; 25: 295–307] RJ Inghamb, R Laia Cellular Signalling 25, 295-307, 2013 | | 2013 |
| The Role of Oncogenic Tyrosine Kinase NPM-ALK in Anaplastic Large Cell Lymphoma Pathobiology S Hegazy | | 2012 |
